Takeda Pharmaceutical as of March 31, 2025
Portfolio Holdings for Takeda Pharmaceutical
Takeda Pharmaceutical holds 11 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Hillevax | 60.2 | $9.8M | 6.7M | 1.45 | |
| Ovid Therapeutics (OVID) | 14.5 | $2.3M | 7.5M | 0.31 | |
| Xilio Therapeutics (XLO) | 6.6 | $1.1M | 1.5M | 0.72 | |
| Equillium (EQ) | 4.4 | $712k | 1.8M | 0.39 | |
| American Well Corp-class A (AMWL) | 3.8 | $613k | 78k | 7.88 | |
| Shattuck Labs (STTK) | 3.0 | $490k | 516k | 0.95 | |
| Lyell Immunopharma | 2.7 | $443k | 823k | 0.54 | |
| Turnstone Biologics Corp (TSBX) | 2.3 | $367k | 896k | 0.41 | |
| Rani Therapeutics Hldgs (RANI) | 1.6 | $256k | 203k | 1.26 | |
| Third Harmonic Bio (THRD) | 0.8 | $128k | 37k | 3.47 | |
| D Fluidigm Corp Del (LAB) | 0.1 | $18k | 17k | 1.08 |
